Chicken melanoma differentiation-associated gene 5 (MDA5) recognizes infectious bursal disease virus infection and triggers MDA5-related innate immunity

被引:57
|
作者
Lee, Chih-Chun [1 ]
Wu, Ching Ching [1 ]
Lin, Tsang Long [1 ]
机构
[1] Purdue Univ, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA
关键词
DOUBLE-STRANDED-RNA; I-LIKE RECEPTORS; RIG-I; EMBRYONIC FIBROBLASTS; ANTIVIRAL RESPONSES; NONENVELOPED VIRUS; SEGMENTS; INTERFERON; PROTEIN; INDUCTION;
D O I
10.1007/s00705-014-1983-9
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The objective of the present study was to determine if chicken melanoma differentiation-associated gene 5 (MDA5) senses infectious bursal disease virus (IBDV) infection to initiate and amplify an innate immune response in the chicken MDA5 (chMDA5) signaling pathway. Chicken embryo fibroblast DF-1 cells were infected with IBDV LP1 at a multiplicity of infection (MOI) of 0.5 or 10. In addition, knockdown and overexpression of chMDA5 were performed by transfecting DF-1 cells with chMDA5-targeting small interfering RNA (siRNA) or chMDA5-expressing DNA. The transfected cells were infected with IBDV LP1 at an MOI of 10. Cell culture supernatants and lysates were collected at 2, 8, 16 and 24 hours postinfection (hpi) for IBDV titer determination and RNA extraction, respectively. IBDV RNA loads and mRNA expression levels of chicken MDA5, interferon-beta (IFN-beta) promoter stimulator 1 (IPS-1), interferon regulatory factor-3 (IRF-3), IFN-beta, double-stranded RNA-dependent protein kinase (PKR), 2',5'-oligoadenylate synthetase (OAS), myxovirus resistance gene (Mx), and major histocompatibility complex class I (MHC class I) were determined by real-time RT-PCR. The IBDV titer increased up to 1.4 x 10(7) plaque-forming units (PFU)/mL at 24 hpi, and the IBDV RNA load reached 464 ng/mu L at 24 hpi. The mRNA expression levels of chicken MDA5, IRF-3, IFN-beta, PKR, OAS, Mx and MHC class I in IBDV-infected DF-1 cells exhibited significant (p < 0.05) upregulation up to 906-, 199-, 26,310-, 12-, 66,144-, 64,039- and 33-fold, respectively. Expressed chMDA5 from transfection and double-stranded RNA from IBDV infection were localized or colocalized in the cytoplasm of DF-1 cells at 16 hpi. When chMDA5 was knocked down in DF-1 cells, IBDV titers and RNA loads were significantly higher (p < 0.05) than those in DF-1 cells without chMDA5 knockdown at 24 hpi. The expression levels of chicken MDA5, IRF-3, IFN-beta and MHC class I in chMDA5-knockdown DF-1 cells were significantly lower (p < 0.05) at 16 and 24 hpi. DF-1 cells overexpressing chMDA5 by transfection with chMDA5 expressing DNA had significantly lower (p < 0.05) IBDV titers and RNA loads at 16 and 24 hpi and showed significantly higher (p < 0.05) expression of chicken MDA5, IRF-3, IFN-beta, PKR, OAS, Mx and MHC class I at 2 hpi. The results indicated that chicken MDA5 recognized IBDV infection and that this interaction resulted in the activation of chMDA5-related innate immune genes and upregulation of chicken MHC class I.
引用
收藏
页码:1671 / 1686
页数:16
相关论文
共 50 条
  • [41] Anti-Melanoma Differentiation Associated Protein 5 (MDA5) Positive Juvenile Dermatomyositis: Focus on the Lung
    McNeill, David Moreno
    Gillispie-Taylor, Miriah
    Baszis, Kevin
    Sayad, Edouard
    Carmona, Manuel Silva
    Vogel, Tiphanie
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [42] A Unique Case of Anti-melanoma Differentiation-associated Gene 5 (Anti-MDA5) Dermatomyositis (DM) Associated With Spontaneous Abortion
    Zimmerman, K. E.
    Gergen, D. J.
    Smith, J. B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [43] Prevalence and reactivity of anti-melanoma differentiation-associated gene 5 (anti-MDA-5) autoantibody in Brazilian patients with dermatomyositis
    Pires Borges, Isabela Bruna
    Silva, Marilda Guimaraes
    Shinjo, Samuel Katsuyuki
    ANAIS BRASILEIROS DE DERMATOLOGIA, 2018, 93 (04) : 517 - 523
  • [44] CLINICAL OUTCOMES OF EXTRACORPOREAL LIFE SUPPORT AND LUNG TRANSPLANTATION IN SEVERE ANTI-MELANOMA DIFFERENTIATION-ASSOCIATED GENE 5 (MDA5)-RAPIDLY PROGRESSIVE INTERSTITIAL LUNG DISEASE: A SYSTEMATIC REVIEW
    Lim, Y.
    Fairley, J.
    Wang, Y.
    Prasad, J.
    Wluka, A.
    Aggarwal, R.
    Cicuttini, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1970 - 1971
  • [45] CLINICAL OUTCOMES OF EXTRACORPOREAL LIFE SUPPORT AND LUNG TRANSPLANTATION IN SEVERE ANTI-MELANOMA DIFFERENTIATION-ASSOCIATED GENE 5 (MDA5)-RAPIDLY PROGRESSIVE INTERSTITIAL LUNG DISEASE: A SYSTEMATIC REVIEW
    Lim, Yuan
    Fairley, Jessica
    Wang, Yuanyuan
    Prasad, Jyotika
    Wluka, Anita
    Aggarwal, Rohit
    Cicuttini, Flavia
    INTERNAL MEDICINE JOURNAL, 2023, 53 : 47 - 48
  • [46] Innate immunity to RNA virus is regulated by temporal and reversible sumoylation of RIG-I and MDA5
    Hu, Ming-Ming
    Liao, Chen-Yang
    Yang, Qing
    Xie, Xue-Qin
    Shu, Hong-Bing
    JOURNAL OF EXPERIMENTAL MEDICINE, 2017, 214 (04): : 973 - 989
  • [47] A fatal interstitial lung disease in an anti-melanoma differentiation-associated gene 5 (anti-MDA5) antibody negative patient with juvenile dermatomyositis
    Yesilbas, Osman
    Yildiz, Mehmet
    Yozgat, Can Yilmaz
    Tahaoglu, Irmak
    Yazan, Hakan
    Cakir, Erkan
    Adrovic, Amra
    Sahin, Sezgin
    Barut, Kenan
    Kasapcopur, Ozgur
    TURKISH JOURNAL OF PEDIATRICS, 2021, 63 (05) : 903 - 908
  • [48] Clinical features and outcome of anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive idiopathic inflammatory myopathies: experience from the Region Vastra Gotaland
    Marklund, J. M.
    Hanna, B.
    Jin, T.
    Pullerits, R.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2021, 50 : 54 - 54
  • [49] The Balance Between Intensive and Palliative Care in an Anti-melanoma Differentiation-Associated Gene 5 (MDA5) Antibody-Positive Acute Interstitial Pneumonia in a Nonagenarian: A Case Report
    Asano, Yuri
    Fujimori, Taichi
    Sano, Chiaki
    Ohta, Ryuichi
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (03)
  • [50] MELANOMA DIFFERENTIATION-ASSOCIATED GENE 5 ANTIBODY (ANTI-MDA5) DERMATOMYOSITIS: CLINICAL FEATURES AND OUTCOME IN A RACIALLY DIVERSE PATIENT COHORT
    Koyoda, S. K.
    Wahezi, D.
    Kumthekar, A.
    Xie, X.
    Mahmood, S.
    Tagoe, C.
    Ayesha, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 711 - 712